# BD Board Declares Dividend
Canonical URL: https://biopharmsignal.com/news/BDX/bd-board-declares-dividend-ea66eb4a
Ticker: BDX
Company: Becton Dickinson
Source: Becton Dickinson
Published: 2026-07-28 20:15 EST
Original Source URL: https://investors.bd.com/news-events/press-releases/detail/965/bd-board-declares-dividend
## Summary

FRANKLIN LAKES, N.J., July 28, 2026 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global…...

## Article Body
, /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $1.05 per common share, payable on September 30, 2026, to holders of record on September 9, 2026. The indicated annual dividend rate is $4.20 per share.

About BD BD is one of the world's largest pure-play medical technology companies with a Purpose of advancing the world of health™ by driving innovation across medical essentials, connected care, biopharma systems and interventional. The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ , X @BDandCo or Instagram @becton_dickinson .

View original content: https://www.prnewswire.com/news-releases/bd-board-declares-dividend-302836855.html

SOURCE BD (Becton, Dickinson and Company)

Released July 28, 2026
## Recent Company News
- 2026-07-28 20:15 EST — [BD Board Declares Dividend](https://biopharmsignal.com/news/BDX/bd-board-declares-dividend-ea66eb4a) — Source: Becton Dickinson
- 2026-07-22 10:55 EST — [Mike Garrison to Retire from BD](https://biopharmsignal.com/news/BDX/mike-garrison-to-retire-from-bd-a251fa3e) — Source: Becton Dickinson
- 2026-07-09 20:15 EST — [BD to Announce Financial Results for its Third Quarter of Fiscal 2026](https://biopharmsignal.com/news/BDX/bd-to-announce-financial-results-for-its-third-quarter-of-fiscal-2026-fae7aaa2) — Source: Becton Dickinson
- 2026-06-23 10:50 EST — [BD Awarded Vizient Innovative Technology Contract for CentroVena One™ Insertion System](https://biopharmsignal.com/news/BDX/bd-awarded-vizient-innovative-technology-contract-for-centrovena-one-insertion-s-a27e1c7c) — Source: Becton Dickinson
- 2026-05-21 10:50 EST — [BD Delivers Kidney Stone Care for Urology Teams with the Elyra™ Thulium Fiber Laser System](https://biopharmsignal.com/news/BDX/bd-delivers-kidney-stone-care-for-urology-teams-with-the-elyratm-thulium-fiber-laser-system) — Source: Becton Dickinson
## Related News
- 2026-07-28 13:00 EST — ENLV — [Enlivex Announces $400,000,000 Private Placement](https://biopharmsignal.com/news/ENLV/enlivex-announces-400-000-000-private-placement-20e71a7a)
- 2026-07-28 12:30 EST — XRAY — [Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship](https://biopharmsignal.com/news/XRAY/dentsply-sirona-advances-commercial-growth-strategy-in-canada-through-expanded-m-e2440bb2)
- 2026-07-28 12:30 EST — RLMD — [Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer](https://biopharmsignal.com/news/RLMD/relmada-therapeutics-appoints-uro-oncology-leader-bipin-dalmia-as-chief-business-5c4d7b11)
- 2026-07-28 12:05 EST — RIGL — [Rigel Announces Conference Call and Webcast to Report Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/RIGL/rigel-announces-conference-call-and-webcast-to-report-second-quarter-2026-financ-5b987d7a)
- 2026-07-28 12:05 EST — GSK — [GSK to establish new flagship R&D centre on Cambridge Biomedical Campus, UK](https://biopharmsignal.com/news/GSK/gsk-to-establish-new-flagship-r-d-centre-on-cambridge-biomedical-campus-uk-6f2bb859)